Recherche
Résultats 21-30 de 298
-
Safety of the extension of use of 2'-fucosyllactose/difucosyllactose (2'-FL/DFL) mixture and lacto- <i>N</i>-tetraose (LNT) as novel foods in food supplements for infants pursuant to Regulation (EU) 2015/2283.
EFSA Journal, 21-03-2022, 20, e07140Article dans une revue scientifiquetexte intégral -
INSPECT: A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel in Patients With Perianal Fistulizing Crohn's Disease Treated in the ADMIRE-CD Trial.
Inflammatory Bowel Diseases, 04-02-2022, 28, 1737–1745Article dans une revue scientifique -
Comparison of outcomes for HLA-matched sibling and haplo-identical donors in Myelodysplastic syndromes: report from the chronic malignancies working party of EBMT.
Blood Cancer Journal, 29-09-2022, 12, 140Article dans une revue scientifiquetexte intégral -
Absence of mortality differences between the 1st and 2nd covid waves in kidney transplant recipients.
Kidney International Reports, 04-10-2022, 7, 2617-2629Article dans une revue scientifiquetexte intégral -
Safety of zinc l-carnosine as a Novel food pursuant to Regulation (EU) 2015/2283 and the bioavailability of zinc from this source in the context of Directive 2002/46/EC on food supplements
EFSA Journal, 27-06-2022, 20, e07332Article dans une revue scientifiquetexte intégral -
Social Environment and Food and Beverage Intake in European Adolescents: The Helena Study.
Journal of the American Nutrition Association, 06-05-2022, 41, 1-13Article dans une revue scientifique -
Safety of <i>Wolffia globosa</i> powder as a Novel food pursuant to Regulation (EU) 2015/2283.
EFSA Journal, 08-01-2022, 19, e06938Article dans une revue scientifiquetexte intégral -
Evaluation of existing guidelines for their adequacy for the food and feed risk assessment of microorganisms obtained through synthetic biology
EFSA Journal, 29-08-2022, 20, -Article dans une revue scientifiquetexte intégral -
Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: a multicenter retrospective study of 59 cases.
Journal of The American Academy of Dermatology, 13-11-2022Article dans une revue scientifiquetexte intégral -
A safety, pharmacokinetic and pharmacodynamic study of sibofimloc, a novel fimh blocker in patients with active crohn's disease.
Journal of Gastroenterology and Hepatology, 12-03-2022Article dans une revue scientifique